Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Chronic pain is often driven less by tissue damage and more by low levels of key neurotransmitters, especially serotonin, norepinephrine, GABA, and dopamine, which power the brain's descending pain-inhibition pathways. When these chemical messengers run low, the spinal cord's "volume control" fails, glutamate signaling goes unchecked, and ordinary sensations register as pain, a process known as central sensitization. This is why conditions like fibromyalgia, migraine, and long-standing nerve pain frequently resist opioids yet respond to medications that restore serotonin and norepinephrine signaling, and why poor sleep, stress, and depression make pain measurably worse. There are several important factors that shape which neurotransmitter systems are involved in your case, and the full explanation below outlines what to consider before assuming a treatment has simply "stopped working."
Because brain chemistry, sleep, mood, and pain overlap in ways that are easy to misread, a free, instant, online symptom check can help you organize your symptoms, spot patterns worth mentioning to a clinician, and understand which next steps make the most sense for you.
Last reviewed for medical accuracy: 08/18/2026
Chronic pain affects more than 20% of adults worldwide, disrupting daily life, mood, sleep and overall well-being. While injury or inflammation can trigger pain, the brain’s chemistry plays a crucial role in how we perceive and manage it. Two key messengers—serotonin and dopamine—help regulate pain signals. When their levels drop, the body’s natural pain-relief system falters, making chronic discomfort harder to shake.
Serotonin
• Often called the “feel-good” neurotransmitter.
• Modulates mood, sleep, appetite and pain inhibition pathways.
• Produced mainly in the gut and brain.
Dopamine
• Drives motivation, reward, movement and certain aspects of pain control.
• Produced in brain regions like the ventral tegmental area and substantia nigra.
• Affects how we evaluate pain as threatening or tolerable.
Reduced Descending Inhibition
The brain uses descending pathways (from the brainstem to the spinal cord) to damp down incoming pain signals. Serotonin and dopamine activate these inhibitory circuits. When their levels are low:
Heightened Central Sensitization
Ongoing pain prompts the nervous system to become hypersensitive—a phenomenon called central sensitization. Low serotonin and dopamine:
Mood and Sleep Disruption
Chronic pain, low mood and poor sleep form a vicious cycle. Low serotonin:
Impaired Reward Processing
Dopamine deficiency dampens the brain’s reward system:
Fibromyalgia
Patients often show reduced cerebrospinal fluid levels of serotonin metabolites and altered dopamine activity, correlating with widespread pain and fatigue.
Migraine
Imaging studies reveal impaired serotonin receptor function in migraine sufferers, contributing to persistent headache patterns.
Irritable Bowel Syndrome (IBS)
Gut-brain axis dysfunction includes low serotonin in the gut lining, amplifying abdominal pain and bowel sensitivity.
Chronic Low Back Pain
Lower dopamine receptor availability has been observed in brain areas responsible for pain modulation, linking reward pathway deficits to persistent back pain.
Watch for a combination of:
If these symptoms sound familiar, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next steps.
Lifestyle Interventions
Sleep Hygiene
Psychological Therapies
Pharmacological Treatments
Complementary Approaches
Improving neurotransmitter balance is often gradual. You may notice small gains first—better sleep, a brighter mood, or slight pain relief. Persistence matters. Combining multiple strategies typically yields the best outcomes. If one approach feels slow or ineffective, talk with your healthcare provider about adding or adjusting treatments.
Chronic pain with low serotonin and dopamine components can be complex. You should speak to a doctor if you experience:
Always treat sudden, severe pain or alarming symptoms as potential emergencies.
Balancing brain chemistry is a key step in managing chronic pain. By understanding the roles of serotonin and dopamine, you can work with your healthcare team to tailor a strategy that combines lifestyle changes, therapy and medication. For a personalized starting point, try a free, online symptom check, using the doctor approved Ubie Symptom Checker. And remember: any potentially serious or life-threatening concern should prompt immediate medical attention—please speak to a doctor without delay.
(References)
* Eisenach JC. Muscarinic-mediated analgesia. Life Sci. 1999;64(6-7):549-54. doi: 10.1016/s0024-3205(98)00600-6. PMID: 10069522.
* Clark JO, Clark TP. Analgesia. Vet Clin North Am Equine Pract. 1999 Dec;15(3):705-23. doi: 10.1016/s0749-0739(17)30140-2. PMID: 10589475.
* Zhao ZQ. Neural mechanism underlying acupuncture analgesia. Prog Neurobiol. 2008 Aug;85(4):355-75. doi: 10.1016/j.pneurobio.2008.05.004. Epub 2008 Jun 5. PMID: 18582529.
* Barter LS. Rabbit analgesia. Vet Clin North Am Exot Anim Pract. 2011 Jan;14(1):93-104. doi: 10.1016/j.cvex.2010.09.003. PMID: 21074705.
* Kjær SW, Rice ASC, Wartolowska K, Vase L. Neuromodulation: more than a placebo effect? Pain. 2020 Mar;161(3):491-495. doi: 10.1097/j.pain.0000000000001727. PMID: 31651581.
* Mokhtari T, Ren Q, Li N, Wang F, Bi Y, Hu L. Transcutaneous Electrical Nerve Stimulation in Relieving Neuropathic Pain: Basic Mechanisms and Clinical Applications. Curr Pain Headache Rep. 2020 Feb 18;24(4):14. doi: 10.1007/s11916-020-0846-1. Epub 2020 Feb 18. PMID: 32072323.
* Chen T, Zhang WW, Chu YX, Wang YQ. Acupuncture for Pain Management: Molecular Mechanisms of Action. Am J Chin Med. 2020;48(4):793-811. doi: 10.1142/S0192415X20500408. Epub 2020 May 15. PMID: 32420752.
* Knotkova H, Hamani C, Sivanesan E, Le Beuffe MFE, Moon JY, Cohen SP, Huntoon MA. Neuromodulation for chronic pain. Lancet. 2021 May 29;397(10289):2111-2124. doi: 10.1016/S0140-6736(21)00794-7. PMID: 34062145.
* Qian X, Zhao X, Yu L, Yin Y, Zhang XD, Wang L, Li JX, Zhu Q, Luo JL. Current status of GABA receptor subtypes in analgesia. Biomed Pharmacother. 2023 Dec;168:115800. doi: 10.1016/j.biopha.2023.115800. Epub 2023 Nov 6. PMID: 37935070.
* Jevtovic-Todorovic V, Todorovic SM. The Role of Neuroactive Steroids in Analgesia and Anesthesia: An Interesting Comeback? Biomolecules. 2023 Nov 15;13(11). doi: 10.3390/biom13111654. Epub 2023 Nov 15. PMID: 38002336; PMCID: PMC10669813.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.